Seqster’s Digital Health Technology: Unveiling a Revolutionary Alzheimer’s Screening Breakthrough
SEQSTER PDM Inc. and Boston University researchers, led by Dr. Rhoda Au, have partnered to develop an innovative early...
SEQSTER PDM Inc. and Boston University researchers, led by Dr. Rhoda Au, have partnered to develop an innovative early...
Appili Therapeutics, a biopharmaceutical company specializing in infectious disease treatments and vaccines, has secured CAD $100 million in funding...
Viridian Therapeutics announced the completion of enrollment in its phase 3 clinical trials, THRIVE and THRIVE-2, targeting patients with...
Mirum Pharmaceuticals has received FDA approval to expand the use of LIVMARLI (maralixibat) oral solution for treating cholestatic pruritus...
Schrödinger, Inc. has embarked on an initiative to enhance its computational platform for early predicting toxicology risk in drug...
The European Medicines Agency (EMA) has recommended approval of Merck’s KEYTRUDA and Padcev combination for the first-line treatment of...
LEO Pharma, a leading dermatology company, announced a positive opinion from the European Medicines Agency (EMA) for Anzupgo® (delgocitinib...
Gilead Sciences’ pivotal Phase 3 PURPOSE 1 trial has revealed compelling efficacy and safety results for lenacapavir, a novel...
The AFFINE study evaluating giroctocogene fitelparvovec, a gene therapy for moderate to severe hemophilia A, has achieved significant results....
A groundbreaking alliance between Worldwide Clinical Trials (Worldwide), Centrum Badan Klinicznych PI-House, and the Polish Psychedelic Society (PTP) aims...